نتایج جستجو برای: Beta interferon -1a

تعداد نتایج: 277060  

Journal: :acta medica iranica 0
mehrdokht mazdeh department of neurology, farshchian hospital, hamadan university of medical sciences, hamadan, iran. saeed afzali department of internal medicine, farshchian hospital, hamadan university of medical sciences, hamadan, iran. mahmood reza jaafari department of radiology, farshchian hospital, hamadan university of medical sciences, hamadan, iran.

we aimed to compare the therapeutic effect of avonex (av), betaferon (be) & rebif (re) on the expanded disability status scale (edss) in multiple sclerosis (ms). ninety patients referring to farshchian hospital were entered in this study. the patients were divided into three equal groups: group 1 received av, group 2 received re and group 3 received be, and after 24 months, comparison was done ...

Journal: :iranian journal of neurology 0
mehrdokht mazdeh department of neurology, farshchian hospital, hamedan university of medical sciences, hamedan, iran. ahmad reza mobaien department of infectious diseases and tropical medicine, valiasr hospital, zanjan university of medical sciences, zanjan, iran

background: available evidence shows that tetracycline family has cellular and molecular mechanisms to protect neurons and oligodendrocytes by modulating matrix metalloproteinases. we tried to compare the effectiveness of intramuscular and subcutaneous interferon beta-1a (inf-β1a) in combination with oral doxycycline among patient with relapsing remitting multiple sclerosis (rrms) and secondary...

Ali Reza Rezaei Ashtiani, Babak Zamani, Mohammad Rohani,

Background: It has been reported that liver function alterations occur in 8–38% of patients with relapsing-remitting multiple sclerosis (RRMS) treated with interferon-beta in controlled clinical trials or in prospective but non-controlled studies. We report herein a case of symptomatic liver dysfunction associated with two-year-period of regular interferon-beta-1a (Avonex®) intramuscular inje...

Journal: :iranian journal of toxicology 0
علیرضا رضایی آشتیانی ali reza rezaei ashtiani department of neurology, vali-e-asr. medical center,arak medical university, arak, iran بابک زمانی babak zamani department of neurology,rasol-e-akram medical center, tehran, iran محمد روحانی mohammad rohani department of neurology,rasol-e-akram medical center, tehran, iran

background: it has been reported that liver function alterations occur in 8–38% of patients with relapsing-remitting multiple sclerosis (rrms) treated with interferon-beta in controlled clinical trials or in prospective but non-controlled studies. we report herein a case of symptomatic liver dysfunction associated with two-year-period of regular interferon-beta-1a (avonex®) intramuscular inject...

Journal: :Reactions Weekly 2021

Multiple sclerosis (MS) is an inflammatory disorder, in which neurons in central nervous system (CNS) become demyelinated .MS is named for its formation of plaques due to sclerosis of myelin. Variable degree of demyelination results in mild, mediate or severe symptomatic episodes of this disease. It is commonly characterized by recurrent relapses and often followed by severe neurological disabi...

Journal: :Arquivos de neuro-psiquiatria 2002
Marco Aurélio Lana-Peixoto Antônio Lúcio Teixeira Vitor Geraldi Haase

Depression and suicide have been reported in association with multiple sclerosis (MS). Some studies show that interferon beta may increase the depression rate. We report a case of depression and suicidal ideation in coincidence with the start of increased doses of interferon beta-1a and their complete reversal following the drug withdrawal. The patient was a 21-year-old man with MS and no past ...

Journal: :مجله علوم اعصاب شفای خاتم 0
ayda radfar student research committee, faculty of medicine, mashhad university of medical sciences, mashhad, iran

multiple sclerosis (ms) is an inflammatory disorder, in which neurons in central nervous system (cns) become demyelinated .ms is named for its formation of plaques due to sclerosis of myelin. variable degree of demyelination results in mild, mediate or severe symptomatic episodes of this disease. it is commonly characterized by recurrent relapses and often followed by severe neurological disabi...

Journal: :The New England journal of medicine 2006
Richard A Rudick William H Stuart Peter A Calabresi Christian Confavreux Steven L Galetta Ernst-Wilhelm Radue Fred D Lublin Bianca Weinstock-Guttman Daniel R Wynn Frances Lynn Michael A Panzara Alfred W Sandrock

BACKGROUND Interferon beta is used to modify the course of relapsing multiple sclerosis. Despite interferon beta therapy, many patients have relapses. Natalizumab, an alpha4 integrin antagonist, appeared to be safe and effective alone and when added to interferon beta-1a in preliminary studies. METHODS We randomly assigned 1171 patients who, despite interferon beta-1a therapy, had had at leas...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید